Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Condition: Triple Negative Breast Neoplasms Interventions: Drug: Pembrolizumab injection; Drug: Capecitabine tablets; Radiation: Local radiotherapy Sponsor: UNICANCER Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials